U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06916169) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042' on April 02.
Brief Summary: The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Pharmacokinetics
Intervention:
DRUG: AG2304
AG2304, Single-dose Oral Administration
DRUG: AG23041 and AG23042
AG23041/AG23042, Single-dose Oral Administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
Published by HT Digital Content Services with permission from Health...